Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis
Purpose: To systematically assess the effectiveness and toxicity of metronomic oral cyclophosphamide (MOC) on recurrent or platinum-refractory ovarian cancer. Methods: We searched the Cochrane Library, Embase, PubMed, CNKI, Weipu, and Wanfang databases for eligible studies. A descriptive statistical...
Main Authors: | Lili Huang, Ting Jiang, Pengcheng Li, Jie Zhang, Xing Luo, Fang Yang, Tao Ren, Ke Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022016875 |
Similar Items
-
Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study
by: Roze Isono-Taniguchi, et al.
Published: (2022-08-01) -
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
by: Piotr J. Wysocki, et al.
Published: (2023-02-01) -
Impressive response to oral metronomic chemotherapy in ovarian cancer
by: Dinesh Shet, et al.
Published: (2022-12-01) -
Metronomic Chemotherapy in Prostate Cancer
by: Piotr J. Wysocki, et al.
Published: (2022-05-01) -
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
by: Mustafa Asowed, et al.
Published: (2023-04-01)